BIOMAT Database Logo BIOMAT Database Logo

[Therapy of glomerulonephritis]. 1995

S Matthias, and E Ritz, and R Waldherr
Medizinische Universitäts-Klinik, Heidelberg.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune

Related Publications

S Matthias, and E Ritz, and R Waldherr
[Therapy of glomerulonephritis].
January 1986, Zeitschrift fur arztliche Fortbildung,
S Matthias, and E Ritz, and R Waldherr
[Glomerulonephritis therapy 1988].
December 1988, Therapeutische Umschau. Revue therapeutique,
S Matthias, and E Ritz, and R Waldherr
QImmunosuppressive therapy of glomerulonephritis.
May 1970, Medizinische Klinik,
S Matthias, and E Ritz, and R Waldherr
[Therapy of chronic glomerulonephritis].
February 1970, Monatsschrift fur Kinderheilkunde,
S Matthias, and E Ritz, and R Waldherr
[Therapy of chronic glomerulonephritis].
November 1985, Kinderarztliche Praxis,
S Matthias, and E Ritz, and R Waldherr
[Recent therapy of glomerulonephritis].
January 1950, Athena; rassegna mensile di biologia, clinica e terapia,
S Matthias, and E Ritz, and R Waldherr
[Pulse therapy of glomerulonephritis].
June 1988, Nihon rinsho. Japanese journal of clinical medicine,
S Matthias, and E Ritz, and R Waldherr
[Therapy of primary glomerulonephritis].
March 1982, Schweizerische medizinische Wochenschrift,
S Matthias, and E Ritz, and R Waldherr
[Therapy of acute glomerulonephritis].
March 1981, La Clinica terapeutica,
S Matthias, and E Ritz, and R Waldherr
[Diet therapy in glomerulonephritis].
June 1974, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!